Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of ICU patients treated with and without propofol
IRCT20150107020592N19Phase 3Completed
- Sponsor
- The Educational, Research and Treatment Center
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of propofol (2 arms), sponsored by The Educational, Research and Treatment Center. Primary endpoint: Effects and risks of using propofol. Started Jan 2018; status: completed.
02
Drugs
propofol
Beyond the preview
Go deeper on IRCT20150107020592N19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150107020592N19.